Paushak Past Earnings Performance
Past criteria checks 2/6
Paushak has been growing earnings at an average annual rate of 9.4%, while the Chemicals industry saw earnings growing at 16.6% annually. Revenues have been growing at an average rate of 10.4% per year. Paushak's return on equity is 13.6%, and it has net margins of 24.1%.
Key information
9.4%
Earnings growth rate
9.6%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 10.4% |
| Return on equity | 13.6% |
| Net Margin | 24.1% |
| Next Earnings Update | 03 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Paushak makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 2,089 | 504 | 306 | 0 |
| 30 Sep 23 | 2,128 | 518 | 295 | 0 |
| 30 Jun 23 | 2,107 | 516 | 286 | 0 |
| 31 Mar 23 | 2,123 | 540 | 273 | 0 |
| 31 Dec 22 | 2,085 | 529 | 251 | 0 |
| 30 Sep 22 | 1,868 | 450 | 236 | 0 |
| 30 Jun 22 | 1,776 | 462 | 226 | 0 |
| 31 Mar 22 | 1,501 | 376 | 220 | 0 |
| 31 Dec 21 | 1,362 | 354 | 219 | 0 |
| 30 Sep 21 | 1,426 | 398 | 217 | 0 |
| 30 Jun 21 | 1,316 | 316 | 212 | 0 |
| 31 Mar 21 | 1,410 | 373 | 205 | 0 |
| 31 Dec 20 | 1,315 | 327 | 232 | 0 |
| 30 Sep 20 | 1,295 | 321 | 225 | 0 |
| 30 Jun 20 | 1,343 | 335 | 221 | 0 |
| 31 Mar 20 | 1,379 | 349 | 181 | 0 |
| 31 Dec 19 | 1,473 | 382 | 203 | 0 |
| 30 Sep 19 | 1,471 | 344 | 201 | 0 |
| 30 Jun 19 | 1,456 | 347 | 234 | 0 |
| 31 Mar 19 | 1,396 | 390 | 185 | 0 |
| 31 Dec 18 | 1,375 | 371 | 185 | 0 |
| 30 Sep 18 | 1,285 | 348 | 171 | 0 |
| 30 Jun 18 | 1,158 | 319 | 157 | 0 |
| 31 Mar 18 | 1,036 | 215 | 140 | 0 |
| 31 Dec 17 | 784 | 184 | 120 | 0 |
| 30 Sep 17 | 691 | 160 | 113 | 0 |
| 30 Jun 17 | 732 | 131 | 108 | 0 |
| 31 Mar 17 | 669 | 109 | 117 | 0 |
| 31 Dec 16 | 683 | 80 | 100 | 23 |
| 30 Sep 16 | 669 | 75 | 98 | 21 |
| 30 Jun 16 | 713 | 99 | 95 | 20 |
| 31 Mar 16 | 779 | 124 | 92 | 0 |
| 31 Dec 15 | 823 | 145 | 129 | 17 |
| 30 Sep 15 | 833 | 154 | 122 | 15 |
| 30 Jun 15 | 775 | 156 | 117 | 12 |
| 31 Mar 15 | 690 | 130 | 70 | 10 |
| 31 Dec 14 | 630 | 100 | 106 | 9 |
| 30 Sep 14 | 572 | 84 | 104 | 8 |
| 30 Jun 14 | 568 | 77 | 102 | 8 |
| 31 Mar 14 | 563 | 88 | 100 | 8 |
| 31 Dec 13 | 551 | 105 | 86 | 9 |
| 30 Sep 13 | 568 | 108 | 83 | 10 |
| 30 Jun 13 | 538 | 93 | 81 | 10 |
Quality Earnings: 532742 has high quality earnings.
Growing Profit Margin: 532742's current net profit margins (24.1%) are lower than last year (25.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 532742's earnings have grown by 9.4% per year over the past 5 years.
Accelerating Growth: 532742's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 532742 had negative earnings growth (-4.6%) over the past year, making it difficult to compare to the Chemicals industry average (-6.1%).
Return on Equity
High ROE: 532742's Return on Equity (13.6%) is considered low.